Arthrosamid®

Arthrosamid® Injections for Knee Osteoarthritis

An innovative hydrogel injection designed to relieve pain, reduce stiffness, and improve knee function in patients with knee osteoarthritis (OA). Unlike other treatments, Arthrosamid integrates with the knee’s joint lining (synovium) to provide long-term cushioning and protection.

Arthrosamid® offers a long-lasting, non-surgical solution for knee osteoarthritis, helping patients regain mobility and improve quality of life.

Currently Arthrosamid® is only available in Australia via application to Canberra (TGA). Dr Ibrahim and his team can help arrange this.

Arthrosamid Australia

How is Arthrosamid® Administered?

Before treatment with Arthrosamid®, you will have a local anaesthetic to numb the area around your knee. You should also be given antibiotics ahead of this to protect you from any potential risk of infection.

Your knee is cleaned prior to treatment. Arthrosamid® is then singularly injected into your knee’s synovial cavity. This is sometimes performed with the help of ultrasound. The needle is then removed and a bandaid is placed over the injection site.

Arthrosamid® distributes within the synovial fluid and begins to stick to and mesh with the synovial tissue.

Frequently Asked Questions

How it works
  • Arthrosamid is a non-biodegradable hydrogel made mostly of water and a cross-linked polyacrylamide backbone.
  • Once injected, it meshes with the synovial tissue, thickening the joint lining and gradually reducing pain.
  • Pain relief usually begins within 6–8 weeks and can last for several years.
  • Adults with knee OA who have not found relief from other treatments like pain medication, physiotherapy, PRP, or hyaluronic acid.
  • Not suitable for patients with joint infections, inflammatory arthritis, recent knee surgery, or certain bleeding disorders.
  • Administered under local anaesthetic, often with ultrasound guidance.
  • Patients take antibiotics beforehand to reduce infection risk.
  • Procedure takes about 30–45 minutes.
  • Most patients can walk and drive afterward, but avoid strenuous activity for 48 hours.
  • Generally safe; mild swelling, redness, or discomfort at the injection site may occur.
  • High success rate, with over 70% of patients experiencing significant pain relief and improved mobility.
  • Arthrosamid is available in Australia via a TGA application.
  • Cost is $4,800 per knee; not covered by Medicare or private health insurance.
  • Initial consultation with Dr Ameer Ibrahim is required; interstate consultations available via video.

Articles

“Runner’s Trots”: The Real Medical Reason Endurance Athletes Sometimes Lose Bowel Control

What really happens when an elite athlete suddenly loses bowel control mid-race? The recent HYROX incident involving Australian athlete Joanna Wietrzyk put “runner’s trots” firmly in the spotlight — but exercise-induced diarrhoea, urgency and even faecal incontinence can happen to athletes at every level. During hard endurance exercise, blood is diverted away from the gut, repetitive impact can stimulate bowel activity, and heat, dehydration and pre-race nutrition can push the digestive system beyond its comfort zone. The result can be a sudden and sometimes very urgent need to go — with surprisingly little warning. So why does it happen, and can you prevent it? Here’s the real physiology behind one of endurance sport’s most awkward problems.

PRP for Knee Osteoarthritis: How Many Injections Do You Need, and How Long Does Relief Last?

If you're considering PRP for knee osteoarthritis, two of the biggest questions are how many injections are needed and how long the results may last. Recent research provides useful insight into both, with many clinical trials using a short course of 2–3 injections rather than a single treatment. Our latest evidence update looks at the durability of PRP, how platelet concentration may influence the length of benefit, and when a repeat course may be considered for patients who respond well.

Rotator Cuff Tendinopathy and PRP: Modest but Durable Benefit

Rotator cuff tendinopathy and partial-thickness tears are common causes of persistent shoulder pain, particularly when symptoms don't settle with rehabilitation alone. Research into PRP is growing, with recent trials suggesting its benefits may be modest but more durable over time compared with corticosteroid injections. Our latest evidence update explores the shoulder-specific research, including partial-thickness tears, injection technique and why precise targeting and a structured strengthening program remain important when considering PRP.